Skip to main content
Equibles

RA CAPITAL MANAGEMENT, L.P.

Position in MGNX — Macrogenics Inc

CIK 1346824 BOSTON, MA
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,612,493
+$3,225,025 QoQ
Shares Held
1,864,176
0.0% QoQ
Ownership
2.93%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#10
of 122 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. MGNX ranks #69 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 10,281,496 $2,742,280,613
2 PBLS
Parabilis Medicines, Inc.
 28,933,371 $791,906,364
3 RYTM
Rhythm Pharmaceuticals, Inc.
 6,666,837 $740,218,912
4 PCVX
Vaxcyte, Inc.
 11,474,599 $667,018,439
5 SION
Sionna Therapeutics, Inc.
 9,905,045 $435,722,929
6 TYRA
Tyra Biosciences, Inc.
 12,198,625 $389,624,082
7 EWTX
Edgewise Therapeutics, Inc.
 8,392,730 $340,996,619
8 NAMS
NewAmsterdam Pharma Co N.V.
 9,883,524 $330,779,298

All Filings in MGNX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,612,493 1,864,176
2026-03-31 $5,387,468 1,864,176
2024-06-30 $8,848,589 2,082,021
2024-03-31 $30,647,349 2,082,021
2023-12-31 $38,990,600 4,053,077
2023-09-30 $1,593,720 342,000
2022-03-31 $53,772,663 6,103,594
2021-12-31 $97,962,683 6,103,594
2021-09-30 $124,458,858 5,943,594
2021-06-30 $159,644,934 5,943,594
2021-03-31 $157,134,968 4,933,594
2020-12-31 $100,017,460 4,375,217
2020-09-30 $110,211,716 4,375,217
2020-06-30 $128,003,483 4,584,652